Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maze Therapeutics (MAZE) Return on Capital Employed (2025 - 2026)

Maze Therapeutics' Return on Capital Employed history spans 2 years, with the latest figure at 34.62% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed fell 3605.0% to 34.62% in Q1 2026 year-over-year; TTM through Mar 2026 was 34.62%, a 3605.0% decrease, with the full-year FY2025 number at 48.23%, changed N/A from a year prior.
  • Return on Capital Employed hit 34.62% in Q1 2026 for Maze Therapeutics, up from 36.92% in the prior quarter.
  • Over the last five years, Return on Capital Employed for MAZE hit a ceiling of 1.43% in Q1 2025 and a floor of 57.73% in Q2 2025.